Prevention of Acute Mountain Sickness in Nepali Porters: A Controlled Trial
β Scribed by Laxmi Vilas Ghimire; Matiram Pun
- Book ID
- 119989186
- Publisher
- Elsevier Science
- Year
- 2007
- Tongue
- English
- Weight
- 61 KB
- Volume
- 18
- Category
- Article
- ISSN
- 1080-6032
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## Objective To determine the impact of sumatriptan prophylaxis on acute mountain sickness (AMS) and altitude headache development within 24 hours of ascent, we designed a doubleβblind, randomized, clinical trial. ## Methods A prospective, doubleβblind, randomized, placeboβcontrolled
## Objectives: Over the last 20 years a number of small trials have reported that spironolactone effectively prevents acute mountain sickness (ams), but to date there have been no large randomized trials investigating the efficacy of spironolactone in prevention of ams. hence, a prospective, double